INTUITIVE SURGICAL INC (ISRG) Stock Fundamental Analysis
USA - NASDAQ:ISRG - US46120E6023 - Common Stock
549.51 USD
-16 (-2.83%)
551 USD
+1.49 (+0.27%)
Overall ISRG gets a fundamental rating of 7 out of 10. We evaluated ISRG against 188 industry peers in the Health Care Equipment & Supplies industry. ISRG scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ISRG is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings could make ISRG a good candidate for growth and quality investing.
1. Profitability
1.1 Basic Checks
ISRG had positive earnings in the past year.
ISRG had a positive operating cash flow in the past year.
In the past 5 years ISRG has always been profitable.
Each year in the past 5 years ISRG had a positive operating cash flow.
1.2 Ratios
ISRG has a Return On Assets of 14.19%. This is amongst the best in the industry. ISRG outperforms 95.77% of its industry peers.
ISRG has a better Return On Equity (16.12%) than 91.01% of its industry peers.
ISRG has a better Return On Invested Capital (14.96%) than 94.71% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ISRG is above the industry average of 8.98%.
The 3 year average ROIC (12.20%) for ISRG is below the current ROIC(14.96%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| ROIC | 14.96% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)12.2%
ROIC(5y)11.86%
1.3 Margins
The Profit Margin of ISRG (28.58%) is better than 95.77% of its industry peers.
ISRG's Profit Margin has declined in the last couple of years.
ISRG has a better Operating Margin (29.44%) than 97.35% of its industry peers.
ISRG's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 66.38%, ISRG is in the better half of the industry, outperforming 70.90% of the companies in the same industry.
In the last couple of years the Gross Margin of ISRG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 29.44% | ||
| PM (TTM) | 28.58% | ||
| GM | 66.38% |
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
2. Health
2.1 Basic Checks
ISRG has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for ISRG has been increased compared to 1 year ago.
The number of shares outstanding for ISRG has been increased compared to 5 years ago.
ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
There is no outstanding debt for ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | N/A |
ROIC/WACC1.7
WACC8.78%
2.3 Liquidity
A Current Ratio of 4.97 indicates that ISRG has no problem at all paying its short term obligations.
With a decent Current ratio value of 4.97, ISRG is doing good in the industry, outperforming 79.37% of the companies in the same industry.
A Quick Ratio of 4.20 indicates that ISRG has no problem at all paying its short term obligations.
ISRG has a better Quick ratio (4.20) than 79.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.97 | ||
| Quick Ratio | 4.2 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 28.12% over the past year.
Measured over the past years, ISRG shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.48% on average per year.
Looking at the last year, ISRG shows a very strong growth in Revenue. The Revenue has grown by 22.18%.
ISRG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.27% yearly.
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
3.2 Future
Based on estimates for the next years, ISRG will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.47% on average per year.
ISRG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.12% yearly.
EPS Next Y19.93%
EPS Next 2Y16.17%
EPS Next 3Y15.85%
EPS Next 5Y15.47%
Revenue Next Year21.17%
Revenue Next 2Y18.1%
Revenue Next 3Y16.53%
Revenue Next 5Y14.12%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 63.82, the valuation of ISRG can be described as expensive.
Based on the Price/Earnings ratio, ISRG is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 25.89. ISRG is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 55.55 indicates a quite expensive valuation of ISRG.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ISRG indicates a somewhat cheap valuation: ISRG is cheaper than 67.72% of the companies listed in the same industry.
ISRG's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 34.59.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 63.82 | ||
| Fwd PE | 55.55 |
4.2 Price Multiples
65.61% of the companies in the same industry are more expensive than ISRG, based on the Enterprise Value to EBITDA ratio.
69.31% of the companies in the same industry are more expensive than ISRG, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 86.73 | ||
| EV/EBITDA | 54.67 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ISRG does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of ISRG may justify a higher PE ratio.
ISRG's earnings are expected to grow with 15.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.2
PEG (5Y)5.56
EPS Next 2Y16.17%
EPS Next 3Y15.85%
5. Dividend
5.1 Amount
No dividends for ISRG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
549.51
-16 (-2.83%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners88.66%
Inst Owner Change3%
Ins Owners0.45%
Ins Owner Change1.04%
Market Cap196.99B
Revenue(TTM)9.61B
Net Income(TTM)2.75B
Analysts78.54
Price Target608.71 (10.77%)
Short Float %2.07%
Short Ratio2.92
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.16%
Min EPS beat(2)11.61%
Max EPS beat(2)18.71%
EPS beat(4)4
Avg EPS beat(4)13.53%
Min EPS beat(4)3.05%
Max EPS beat(4)20.76%
EPS beat(8)8
Avg EPS beat(8)11%
EPS beat(12)11
Avg EPS beat(12)7.6%
EPS beat(16)13
Avg EPS beat(16)5.75%
Revenue beat(2)2
Avg Revenue beat(2)2%
Min Revenue beat(2)1.84%
Max Revenue beat(2)2.17%
Revenue beat(4)4
Avg Revenue beat(4)2.55%
Min Revenue beat(4)1.09%
Max Revenue beat(4)5.12%
Revenue beat(8)5
Avg Revenue beat(8)1.17%
Revenue beat(12)6
Avg Revenue beat(12)0.55%
Revenue beat(16)8
Avg Revenue beat(16)0.31%
PT rev (1m)1.89%
PT rev (3m)1.63%
EPS NQ rev (1m)3.21%
EPS NQ rev (3m)3.33%
EPS NY rev (1m)5.63%
EPS NY rev (3m)9.92%
Revenue NQ rev (1m)1.65%
Revenue NQ rev (3m)1.69%
Revenue NY rev (1m)1.17%
Revenue NY rev (3m)1.34%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 63.82 | ||
| Fwd PE | 55.55 | ||
| P/S | 20.49 | ||
| P/FCF | 86.73 | ||
| P/OCF | 66.54 | ||
| P/B | 11.56 | ||
| P/tB | 11.8 | ||
| EV/EBITDA | 54.67 |
EPS(TTM)8.61
EY1.57%
EPS(NY)9.89
Fwd EY1.8%
FCF(TTM)6.34
FCFY1.15%
OCF(TTM)8.26
OCFY1.5%
SpS26.81
BVpS47.54
TBVpS46.57
PEG (NY)3.2
PEG (5Y)5.56
Graham Number95.97
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| ROCE | 16.61% | ||
| ROIC | 14.96% | ||
| ROICexc | 29.62% | ||
| ROICexgc | 30.86% | ||
| OM | 29.44% | ||
| PM (TTM) | 28.58% | ||
| GM | 66.38% | ||
| FCFM | 23.63% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)12.2%
ROIC(5y)11.86%
ROICexc(3y)18.44%
ROICexc(5y)19.03%
ROICexgc(3y)19.29%
ROICexgc(5y)20.12%
ROCE(3y)13.54%
ROCE(5y)13.16%
ROICexgc growth 3Y-7.59%
ROICexgc growth 5Y-7%
ROICexc growth 3Y-6.87%
ROICexc growth 5Y-6.06%
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
F-Score8
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 111.36% | ||
| Cap/Sales | 7.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 85.84% | ||
| Profit Quality | 82.69% | ||
| Current Ratio | 4.97 | ||
| Quick Ratio | 4.2 | ||
| Altman-Z | N/A |
F-Score8
WACC8.78%
ROIC/WACC1.7
Cap/Depr(3y)197.35%
Cap/Depr(5y)162.98%
Cap/Sales(3y)12.27%
Cap/Sales(5y)10.16%
Profit Quality(3y)56.77%
Profit Quality(5y)75.99%
High Growth Momentum
Growth
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
EPS Next Y19.93%
EPS Next 2Y16.17%
EPS Next 3Y15.85%
EPS Next 5Y15.47%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
Revenue Next Year21.17%
Revenue Next 2Y18.1%
Revenue Next 3Y16.53%
Revenue Next 5Y14.12%
EBIT growth 1Y36.82%
EBIT growth 3Y8.76%
EBIT growth 5Y11.37%
EBIT Next Year40.01%
EBIT Next 3Y23.66%
EBIT Next 5Y20.46%
FCF growth 1Y80.69%
FCF growth 3Y-9.1%
FCF growth 5Y2.14%
OCF growth 1Y46.32%
OCF growth 3Y4.95%
OCF growth 5Y8.61%
INTUITIVE SURGICAL INC / ISRG FAQ
Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?
ChartMill assigns a fundamental rating of 7 / 10 to ISRG.
Can you provide the valuation status for INTUITIVE SURGICAL INC?
ChartMill assigns a valuation rating of 4 / 10 to INTUITIVE SURGICAL INC (ISRG). This can be considered as Fairly Valued.
How profitable is INTUITIVE SURGICAL INC (ISRG) stock?
INTUITIVE SURGICAL INC (ISRG) has a profitability rating of 8 / 10.
What is the financial health of INTUITIVE SURGICAL INC (ISRG) stock?
The financial health rating of INTUITIVE SURGICAL INC (ISRG) is 7 / 10.